ArticleOncotarget2016

miR-7 reverses the resistance to BRAFi in melanoma by targeting EGFR/IGF-1R/CRAF and inhibiting the MAPK and PI3K/AKT signaling pathways.

Xiaoyan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.